Androderm > Salt Lake City
Please select a testosterone article from the list below:
- Business Wire - TheraTech Inc. Reports Continued Earnings Gains; Firm Posts 10th Successive Profitable Quarter
- Business Wire - TheraTech's Androderm Is Launched In Germany
- Business Wire - Results of Studies with TheraTech Testosterone Systems for Treatment of HIV-Infected Men and Women with Testosterone Deficiencies Presented at Endocrine...
- Business Wire - TheraTech, Inc./Schwarz Pharma Agreement Expands Androderm Distribution To 13 More Countries
- Business Wire - Supplemental New Drug Application submitted for new, 5 mg Androderm testosterone transdermal "unipatch"
- Business Wire - TheraTech and Astra receive clearance to market testosterone patch in Denmark
- Business Wire - Boston study to evaluate new testosterone patch for treatment of women with AIDS wasting syndrome
- Business Wire - TheraTech and Astra announce second European launch of testosterone patch
- Business Wire - TheraTech reports first quarter financial results
Wednesday 21st of October 1998
Business Wire - TheraTech Inc. Reports Continued Earnings Gains; Firm Posts 10th Successive Profitable Quarter
Wednesday 21st of October 1998, 12:00 amOctober 21, 1998 -- SALT LAKE CITY--(BUSINESS WIRE)--Oct. 21, 1998--TheraTech Inc. (Nasdaq:THRT) Wednesday reported third quarter earnings of $2,421,000 or $0.11 per...
Tuesday 7th of July 1998
Business Wire - TheraTech's Androderm Is Launched In Germany
Tuesday 7th of July 1998, 12:00 amJuly 7, 1998 -- SALT LAKE CITY--(BW HealthWire)--July 7, 1998--TheraTech Inc. (NASDAQ:THRT) Tuesday announced that its 2.5 mg/day Androderm(R) transdermal...
Tuesday 30th of June 1998
Business Wire - Results of Studies with TheraTech Testosterone Systems for Treatment of HIV-Infected Men and Women with Testosterone Deficiencies Presented at Endocrine...
Tuesday 30th of June 1998, 12:00 amJune 30, 1998 -- PHILADELPHIA and SALT LAKE CITY--(BW HealthWire)--June 30, 1998-- The results from two studies evaluating transdermal testosterone replacement in...
Thursday 18th of December 1997
Business Wire - TheraTech, Inc./Schwarz Pharma Agreement Expands Androderm Distribution To 13 More Countries
Thursday 18th of December 1997, 12:00 amDecember 18, 1997 -- SALT LAKE CITY, and MONHEIM, Germany--(BW HealthWire)--Dec. 18, 1997--TheraTech, Inc. (Nasdaq: THRT) and Schwarz Pharma AG today announced an...
Tuesday 29th of October 1996
Business Wire - Supplemental New Drug Application submitted for new, 5 mg Androderm testosterone transdermal "unipatch"
Tuesday 29th of October 1996, 12:00 amOctober 29, 1996 -- PHILADELPHIA and SALT LAKE CITY--(BUSINESS WIRE)--Oct. 29, 1996-- SmithKline Beecham (NYSE:SBH) and TheraTech Inc. (NASDAQ:THRT) Tuesday announced...
Thursday 5th of September 1996
Business Wire - TheraTech and Astra receive clearance to market testosterone patch in Denmark
Thursday 5th of September 1996, 12:00 amSeptember 5, 1996 -- SALT LAKE CITY and SODERTALJE, Sweden--(BUSINESS WIRE)-- Sept. 5, 1996--TheraTech Inc. (NASDAQ:THRT) and Astra AB Thursday announced that ATMOS(R),...
Wednesday 4th of September 1996
Business Wire - Boston study to evaluate new testosterone patch for treatment of women with AIDS wasting syndrome
Wednesday 4th of September 1996, 12:00 amSeptember 4, 1996 -- BOSTON--(BUSINESS WIRE)--Sept. 4, 1996--The Massachusetts General Hospital, a teaching hospital of the Harvard Medical School, and TheraTech Inc....
Wednesday 14th of August 1996
Business Wire - TheraTech and Astra announce second European launch of testosterone patch
Wednesday 14th of August 1996, 12:00 amAugust 14, 1996 -- SALT LAKE CITY and SODERTALJE, Sweden--(BUSINESS WIRE)-- Aug. 14, 1996--TheraTech Inc. (NASDAQ:THRT) and Astra AB Wednesday announced that Astra has...
Tuesday 23rd of April 1996
Business Wire - TheraTech reports first quarter financial results
Tuesday 23rd of April 1996, 12:00 amApril 23, 1996 -- SALT LAKE CITY--(BUSINESS WIRE)--April 23, 1996--TheraTech Inc. (NASDAQ:THRT) Tuesday reported first quarter 1996 operating results. For the three...